期刊文献+

琥珀酸脱氢酶缺陷型肾癌的临床病理特征 被引量:1

Clinicopathological features of succinate dehydrogenase-deficient renal cell carcinoma
下载PDF
导出
摘要 目的探讨琥珀酸脱氢酶(succinate dehydrogenase,SDH)缺陷型肾癌的临床病理特征、诊断及治疗。方法分析SDH缺陷型肾癌的临床病理特征、免疫表型及分子遗传学特征。结果肾肿瘤灶呈实性、灰黄色,质软。镜检见肿瘤边界清楚,细胞排列呈实性、巢状、小管状,细胞质空泡状,胞质内含嗜酸性或浅染的絮状物质,未见核分裂像及坏死。免疫组织化学染色显示PAX8、CK(AE1/AE3)、EMA、P504s均阳性,SDHB阴性。患者组织蜡块全外显子测序结果提示SDHB基因外显子区域发现一处杂合突变。(c.725G>Ap.R242H)。结论SDH缺陷型肾癌发病率罕见,具有特征性的病理组织形态学表现、免疫表型呈特征性的SDHB表达缺失。在临床诊疗过程中,应详细询问患者病情及家族遗传史,必要时进行基因检测明确诊断。 Objective To investigate the clinicopathological features,diagnosis and treatment of succinate dehydrogenase(SDH)–deficient renal cell carcinoma.Methods The clinical and pathological features,immunophenotype and molecular genetic characteristics of SDH-deficient renal cell carcinoma were retrospectively analyzed.Results The kidney tumor was solid,gray-yellow and soft.Microscopic observation showed that the tumor boundary was clear,the cells were arranged in solid,nested,small tubular growth,the cytoplasm was vacuolated,and contained eosinophilic or lightly stained flocculent material,and no mitotic figures and necrosis were seen.Immunohistochemical staining showed that the tumor tissue were positive for PAX8,CK(AE1/AE3),EMA,P504s but negative for SDHB.The whole exon sequencing results of the wax block of the patient’s tissues suggested that a heterozygous mutation was found in the exon region of the SDHB gene.(c.725G>Ap.R242H).Conclusion The incidence of SDH-deficient renal cell carcinoma is rare,with a characteristic pathohistological morphological manifestation and lack of SDHB expression in the immunophenotype.In the clinical diagnosis and treatment process,the patient’s condition and family genetic history should be asked in detail,and genetic testing should be performed to confirm the diagnosis if necessary.
作者 朱清 李楠 武侠 黄园莉 唐明洋 吴礼高 Zhu Qing;Li Nan;Wu Xia;Huang Yuanli;Tang Mingyang;Wu Ligao(Department of Pathology,the First Affiliated Hospital of Bengbu Medical College,Bengbu 233004;Department of Pathology,Bengbu Medical College,Bengbu 233030,China)
出处 《中国组织化学与细胞化学杂志》 CAS CSCD 2020年第6期529-533,共5页 Chinese Journal of Histochemistry and Cytochemistry
基金 国家级大学生创新创业训练计划(201810367025) 蚌埠医学院自然科学基金重点项目(BYKY1822ZD)。
关键词 肾脏肿瘤 SDHB 免疫组织化学 基因检测 Kidney tumor SDHB immunohistochemistry genetic testing
  • 相关文献

参考文献2

二级参考文献16

  • 1Moch H, Humphrey P, Ulbright T, et al. WHO classification of tumours of the urinary system and male genital organ [ M 1. Lyon : IARC Press, 2016.
  • 2Srigley JR, Delahunt B, Eble JN, et al. The International Society of Urological Pathology (ISUP) vancouver classification of renal neoplasia[ J ]. Am J Surg Pathol, 2013,37 ( 10 ) : 1469-1489. DOI: 10. 1097/PAS. 0b013e318299f2dl.
  • 3Yakirevich E, Magi-Galluzzi C, Grada Z, et al. Cadherin 17 is a sensitive and specific marker for metanephric adenoma[ J]. Am J Surg Pathol, 2015, 39 (4) : 479-486. DOI: 10. 1097/PAS.
  • 4Rao Q, Xia QY, Wang ZY, et al. Frequent co-inactivation of the SWI/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours [ J ]. Histopathology, 2015,67 ( 1 ) : 121-129. DOI:10. llll/his. 12632.
  • 5Rao Q, Cheng L, Xia QY, et al. Cathepsin K expression in a wide spectrum of perivascular epithelioid cell neoplasms (PEComas): a clinicopathological study emphasizing extrarenal PEComas[J]. Histopathology, 2013,62(4) :642-650. DOI: 10. 1111/his. 12059.
  • 6Rao Q, Shen Q, Xia QY, et al. PSF/SFPQ is a very common gene fusion partner in TFF3 rearrangement-associated perivaseular epithelioid cell tumors (PEComas) and melanotie Xpl 1 translocationrenal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity [ J ]. Am J Surg Pathol, 2015, 39 (9): 1181-1196. DOI: I0. 1097/PAS. 502.
  • 7Rao Q, Liu B, Cheng L, et al. Renal cell carcinomas with t (6; 11 )( p21 ;q12): a clinicopathologic study emphasizing unusual morphology, novel alpha-TFEB gene fusion point, immunobiomarkers, and uhrastructural features, as well as detection of the gene fusion by fluorescence in situ hybridization [J]. Am J Surg Pathol, 2012,36(9):1327-1338. DOI: 10. 1097/PAS. 0bO13e31825aafb5.
  • 8Rao Q, Williamson SR, Zhang S, et al. TFE3 break-apart FISH has a higher sensitivity for Xpl 1.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum[J]. Am J Surg Pathol, 2013,37 (6) : 804-815. DOI: 10. 1097/PAS. ObO13e31827e17eb.
  • 9Pflueger D, Sboner A, Storz M, et al. Identification of molecular tumor markers in renal cell carcinomas with TFE3 protein expression by RNA sequencing [ J ]. Neoplasia, 2013,15 ( 11 ) : 1231-1240.
  • 10Cancer Genome Atlas Research Network; Linehan WM, Spellman PT, et al. Comprehensive molecular characterization of papillary renal-cell carcinoma[J]. N Engl J Med, 2016, 374 (2) : 135- 145. DOI: 10. 1056/NEJMoa1505917.

共引文献72

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部